The Social Chain AG

  • WKN: A1YC99
  • ISIN: DE000A1YC996
  • Land: Deutschland

Nachricht vom 30.12.2019 | 21:30

The Social Chain AG: The Social Chain AG increases its current stake in SOLIDMIND Nutrition GmbH into a majority stake and furthermore acquires all shares in CONTEAM : BELOW GmbH

The Social Chain AG / Key word(s): Takeover/Capital Increase
The Social Chain AG: The Social Chain AG increases its current stake in SOLIDMIND Nutrition GmbH into a majority stake and furthermore acquires all shares in CONTEAM : BELOW GmbH

30-Dec-2019 / 21:30 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication Pursuant to Article 17 MAR

The Social Chain AG increases its current stake in SOLIDMIND Nutrition GmbH into a majority stake under issuance of new shares by way of capital increase in kind and payment of a cash purchase price and furthermore acquires all shares in CONTEAM : BELOW GmbH

Berlin, December 30, 2019 - With the approval of the Supervisory Board, the Management Board of The Social Chain AG (WKN: A1YC99, ISIN: DE000A1YC996, ticker: PU11) (the "Company") has resolved today to increase the Company's share capital with exclusion of shareholders' subscription rights. The capital increase shall be effected against contribution in kind with partial utilization of the existing authorized capital pursuant to Section 3 (6) of the Articles of Association of the Company. The Company's share capital will be increased from EUR 10,114,118.00 by EUR 75,600.00 to EUR 10,189,718.00 through the issue of 75,600 new no-par- value registered shares with a notional value in the share capital of EUR 1.00 per share.

Only the shareholder of SOLIDMIND Nutrition GmbH, Mr. Lars Müller, is authorized to subscribe for the 76,500 new shares to be issued. In return, he will contribute approx. 19% of the entire share capital in SOLIDMIND Nutrition GmbH into the Company on the basis of a contribution agreement already concluded within the scope of the aforementioned capital increase through contribution in kind. The total of 75,600 new shares will be issued at an issue price of EUR 20.00 per share.

The Company acquires further 3.1% of the share capital of SOLIDMIND Nutrition GmbH against payment of a fixed cash purchase price in a low six-digit amount and will control the majority of the share capital of SOLIDMIND Nutrition GmbH subsequently after the capital increase in kind has been successfully registered in the commercial register.

Furthermore, the Company - represented by its supervisory board - has acquired the entire share capital of CONTEAM : BELOW GmbH with registered seat in Mainz by way of a notarized purchase agreement as of today against payment of a fixed cash purchase price in a low million Euro range.

 

About THE SOCIAL CHAIN AG

As the first integrated social media company, THE SOCIAL CHAIN AG combines social media and social commerce, integrated through its own tech platform LINKS. The company is a pioneer in the creation, development and scaling of social media brands. The company's headquarters are in Berlin with additional offices in Manchester, London, New York and Munich.

 

Contact:
Jana Walker | Investor Relations
ir@socialchain.com


30-Dec-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

News im Fokus

Allianz SE: Allianz kündigt Abschluss eines Rückversicherungsvertrages in den USA an

03. Dezember 2021, 07:03

Aktueller Webcast

Deutsche Konsum REIT-AG

FY 2020/2021 Financial Results

16. Dezember 2021

Aktuelle Research-Studie

CEWE Stiftung & Co. KGaA

Original-Research: CEWE Stiftung & Co. KGaA (von GSC Research GmbH): Kaufen

02. Dezember 2021